DH
QUALITY CONTROL FOR SAMPLE COLLECTION, PROCESSING, AND BIOBANKING IN THE MULTI-CENTER ENVIRONMENT DETERMINANTS OF ISLET AUTOIMMUNITY (ENDIA) STUDY
Published on by Dao Huynh
ENDIA is a multi-centre study that collects a variety of biospecimens longitudinally from pregnant women and their infants to investigate the aetiology of type 1 diabetes. The Quality Control (QC) Working Group identified and evaluated four high-risk “P” activities in the biospecimen collection and processing pipeline where sample or data quality could be adversely impacted if uncontrolled.
- High-risk activity 1: Processing-Sample processing times
- High-risk activity 2: Passage-Shipping and temperature monitoring
- High-risk activity 3: Proficiency testing
- High-risk activity 4: Primary Outcome-Islet autoantibody testing
Cite items from this project
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
